Awakn's Second Licensing Partnership Agreement In A Week, This Time In Canada: Ketamine For Pain Comorbidities
Psychedelics therapeutics biotech company Awakn Life Sciences Corp. (OTCQB: AWKNF) has signed what constitutes its first licensing partnership deal in Canada.
